Incorporation of in vitro drug metabolism data into physiologically-based pharmacokinetic models.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Toxicology in Vitro

• Publication date

  1997-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0887-2333(97)00056-8PMID 20654337
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices.

  1997cited by this paper
• Scaling factors to relate drug metabolic clearance in hepatic microsomes, isolated hepatocytes, and the intact liver: studies with induced livers involving diazepam.

  1997cited by this paper
• Kinetics of drug metabolism in rat liver slices. II. Comparison of clearance by liver slices and freshly isolated hepatocytes.

  1996cited by this paper
• Kinetics of diazepam metabolism in rat hepatic microsomes and hepatocytes and their use in predicting in vivo hepatic clearance.

  1995cited by this paper
• Kinetics of drug metabolism in rat liver slices. Rates of oxidation of ethoxycoumarin and tolbutamide, examples of high- and low-clearance compounds.

  1995cited by this paper
• Prediction of in vivo disposition from in vitro systems: clearance of phenytoin and tolbutamide using rat hepatic microsomal and hepatocyte data.

  1995cited by this paper
• Immunohistochemistry of drug-metabolizing enzymes.

  1995cited by this paper
• Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance.

  1994cited by this paper
• Clearance approaches in pharmacology.

  1987cited by this paper
• Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.

  1977cited by this paper

• Quantitative in vitro to in vivo extrapolation for human toxicology and drug development

  2024cites this paper
• IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making

  2022cites this paper
• Determination of Reference Values of Some Hematological and Immunological Parameters in Healthy Russian Sturgeon (Acipenser gueldenstaedtii)

  2020cites this paper
• Predictions of bisphenol A hepatic clearance in the isolated perfused rat liver (IPRL): impact of albumin binding and of co-administration with naproxen

  2018cites this paper
• Toxic Effects of Water Pollution on Two Bio-indicators of Aquatic Resources of Asa River, Nigeria

  2018cites this paper
• Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation

  2017cites this paper
• Online monitoring of hepatic rat metabolism by coupling a liver biochip and a mass spectrometer.

  2017cites this paper
• Evaluation of the effects of ischemic preconditioning on the hematological parameters of rats subjected to intestinal ischemia and reperfusion

  2015cites this paper
• Evaluation of a liver microfluidic biochip to predict in vivo clearances of seven drugs in rats.

  2014cites this paper
• Haematological and histological changes in fish exposed to the wastewater from the factory 139

  2014cites this paper
• Analysis of the effect of Ischemia and reperfusion on neutrophil proteome in rats

  2014cites this paper
• In Vitro Approaches to Predictive Biokinetics

  2014cites this paper
• In vitro glucuronidation of the angiotensin II receptor antagonist telmisartan in the cat: a comparison with other species.

  2013cites this paper
• The effect of water-soluble fraction of diesel oil on some hematological indices in the great sturgeon Huso huso

  2012cites this paper
• Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model

  2011cites this paper
• Kinetic modelling of in vitro cell-based assays to characterize non-specific bindings and ADME processes in a static and a perfused fluidic system.

  2011cites this paper
• Inhibitive effect of cremophor RH40 or tween 80-based self-microemulsiflying drug delivery system on cytochrome P450 3A enzymes in murine hepatocytes

  2010cites this paper
• Inhibitive effect of cremophor RH40 or tween 80-based self-microemulsiflying drug delivery system on cytochrome P450 3A enzymes in murine hepatocytes

  2010cites this paper
• Biokinetic Modeling and in Vitro–in Vivo Extrapolations

  2010cites this paper
• Physiologically Based Pharmacokinetic Modeling of Drug Disposition in Rat and Human: A Fuzzy Arithmetic Approach

  2008cites this paper
• Pour l'obtention du Grade de DOCTEUR DE L'UNIVERSITE DE POITIERS (Faculté des Sciences Fondamentales et Appliquées) (Diplôme National - Arrêté du 7 août 2006)

  2008cites this paper
• Oxygen Carriers for a Novel Bio-Artificial Liver Support System

  2008cites this paper
• Toxicokinetics in Fishes

  2008cites this paper
• Etude comparative de deux ionophores carboxyliques chez la volaille : apport de la modélisation pharmacocinétique basée sur la physiologie

  2008cites this paper
• ESTABLISHMENT OF RAT PRECISION‐CUT FIBROTIC LIVER SLICE TECHNIQUE AND ITS APPLICATION IN VERAPAMIL METABOLISM

  2007cites this paper
• Comparison of Intrinsic Clearance in Liver Microsomes and Hepatocytes from Rats and Humans: Evaluation of Free Fraction and Uptake in Hepatocytes

  2006cites this paper
• The Assessment of Repeated Dose Toxicity In Vitro: A Proposed Approach

  2006cites this paper
• Mechanism-Based Inhibition of Cytochrome P450 3A4 by Therapeutic Drugs

  2005cites this paper
• Modeling the in vitro intrinsic clearance of the slowly metabolized compound tolbutamide determined in sandwich-cultured rat hepatocytes.

  2004cites this paper
• An in vivo microdialysis method for the qualitative analysis of hepatic phase I metabolites of phenol in rainbow trout (Oncorhynchus mykiss).

  2003cites this paper
• The Prediction of Systemic Toxicity by Integrating the Results of Biokinetic Models and Biologically Based In Vitro Test Methods

  2002cites this paper
• The Practical Applicability of Toxicokinetic Models in the Risk Assessment of Chemicals

  2002cites this paper
• The applicability of in vitro-derived data in hazard identification and characterisation of chemicals.

  2002cites this paper
• PREDICTING PHARMACOKINETICS AND DRUG INTERACTIONS IN PATIENTS FROM IN VITRO AND IN VIVO MODELS: THE EXPERIENCE WITH 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID (DMXAA), AN ANTI-CANCER DRUG ELIMINATED MAINLY BY CONJUGATION

  2002cites this paper
• A COMMENTARY ON THE USE OF HEPATOCYTES IN DRUG METABOLISM STUDIES DURING DRUG DISCOVERY AND DEVELOPMENT*

  2000influential citation
• Comparison of imidazole- and 2-methyl imidazole-containing farnesyl-protein transferase inhibitors: interaction with and metabolism by rat hepatic cytochrome P450s.

  2000cites this paper
• The importance of hepatocytes in drug metabolism studies: an industrial perspective

  2000cites this paper
• Utility of hepatocytes to model species differences in the metabolism of loxtidine and to predict pharmacokinetic parameters in rat, dog and man.

  1999cites this paper
• The Integrated Use of Alternative Methods in Toxicological Risk Evaluation

  1999cites this paper
• Alterations of the catalytic activities of drug-metabolizing enzymes in cultures of human liver slices.

  1998cites this paper